Fetal Tissue Extract for Bone Mineralization and Consolidation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for bone disorders and diseases primarily focus on bone resorbing and forming cells, neglecting the systemic interactions with other tissues, which limits their effectiveness in addressing aging-related bone challenges.
Innovation Solution
The use of extracts from fetal or newborn animal tissues, particularly brain extracts, to promote osteogenic differentiation and enhance bone consolidation through the administration of porcine brain extract (PBE) or whole fetal extracts, which contain bioactive components that stimulate bone formation and repair.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional medicaments targeting bone resorbing and forming cells are used, then bone cell activity is modulated, but systemic bone quality improvement is limited
Solution Approach 1:
The patent introduces fetal tissue extract as an intermediary substance that mediates systemic bone health improvement. The extract contains growth factors and bioactive molecules that act as messengers between different tissues and the bone system, enabling coordinated bone formation and remodeling across multiple organ systems rather than direct cellular targeting
Solution Approach 2:
The invention changes the therapeutic parameter from direct bone cell targeting to systemic biochemical signal modulation. By administering fetal tissue extract containing multiple growth factors (TGF-β, BMPs, IGFs), the treatment shifts from localized cell activity modulation to systemic parameter changes that enhance bone quality through multiple parallel pathways
2Productivity
If fetal tissue extract is used to promote osteogenic differentiation, then bone formation is enhanced, but treatment complexity increases
Solution Approach 1:
The patent segments the complex fetal tissue into specific extractable components containing growth factors and bioactive molecules. Rather than using whole fetal tissue, the invention isolates and administers specific soluble factors (TGF-β, BMPs, IGFs) that can be produced through controlled extraction and purification processes, reducing preparation complexity while maintaining efficacy
Solution Approach 2:
The invention creates a simplified copy or representation of the natural fetal tissue's therapeutic action. Instead of administering actual fetal tissue, the patent produces extract formulations that replicate the beneficial biochemical signals (growth factors and cytokines) that naturally promote osteogenesis, eliminating the need for complex tissue handling while preserving therapeutic effects
Data Source
Figure 1
Figure 2a~2c
Figure 3a~4c
AI summary
Provided are fetal tissue cells or a fetal tissue extract which can effectively prevent or treat bone disorders or diseases.